Search

Search results

427 results found

Update on paclitaxel for femoral-popliteal occlusive disease in the 15 months following a summary level meta-analysis demonstrated increased risk of late mortality and dose response to paclitaxel.

Schneider, Peter A, Ramon L Varcoe, Eric Secemsky, Marc Schermerhorn, and Andrew Holden. 2021. “Update on Paclitaxel for Femoral-Popliteal Occlusive Disease in the 15 months Following a Summary Level Meta-Analysis Demonstrated Increased Risk of Late Mortality and Dose Response to Paclitaxel.”. Journal of Vascular Surgery 73 (1): 311-22.